Independent
Tenure on this board
4.0 yrs
Meeting calendar
INNV · Annual meeting · Thursday, December 4, 2025
Innovage Holding Corp
3 nominees · 2 ballot items.
The meeting will vote on two proposals: (1) election of three Class II directors to serve until 2028 and (2) ratification of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2026.
Market cap
$1.6B
1Y TSR
+172.8%
Board grade
B-
Record date
Oct 14, 2025
Filing
DEF 14A
Meeting concluded · Dec 4, 2025
Follow how the vote landed and what changed on Innovage Holding Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot2
- 1
Election of Class II Directors
ManagementBoard: FORTo elect three Class II directors to serve on the Board until the annual meeting in 2028 and until their successors are duly elected and qualified.
- 2
Ratification of the Appointment of Deloitte & Touche LLP as the Independent Registered Public Accounting Firm
ManagementBoard: FORTo ratify Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2026.
Director elections
Nominees on the ballot3
Independent
Tenure on this board
2.9 yrs
Independent
Tenure on this board
5.4 yrs
Also a director at
Molina Healthcare Inc (MOH)
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | T. Rowe Price Investment Management, Inc. | 4.5% | 6,133,110 | $49M |
| 2 | Coliseum Capital Management, LLC | 0.8% | 1,114,809 | $9M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 0.6% | 877,136 | $7M |
| 4 | BlackRock, Inc. | 0.5% | 644,062 | $5M |
| 5 | Hillsdale Investment Management Inc. | 0.4% | 529,984 | $4M |
| 6 | BlackRock, Inc. | 0.4% | 506,686 | $4M |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 0.4% | 496,886 | $4M |
| 8 | STATE STREET CORP | 0.3% | 431,426 | $3M |
| 9 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.3% | 417,538 | $3M |
| 10 | RENAISSANCE TECHNOLOGIES LLC | 0.3% | 370,817 | $3M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Innovage Holding Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Anaptysbio IncANAB
Annual meeting·Aug 11, 2026·$1.7B
Trulieve Cannabis CorpTRLV
Special meeting·Aug 5, 2026·$1.7B
Avanos Medical IncAVNS
Special meeting·Jul 22, 2026·$1.2B
Prestige Consumer Healthcare IncPBH
Annual meeting·Aug 4, 2026·$2.4B
Aura Biosciences IncAURA
Special meeting·Aug 5, 2026·$723M
Indaptus Therapeutics IncINDP
Annual meeting·Aug 10, 2026·$287M
Reference
Frequently asked questions
- When is the Innovage Holding Corp 2025 annual meeting?
- Innovage Holding Corp (INNV) holds its 2025 annual shareholder meeting on Thursday, December 4, 2025.
- What is the record date for the Innovage Holding Corp 2025 meeting?
- The record date for the Innovage Holding Corp 2025 meeting is Tuesday, October 14, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Innovage Holding Corp's 2025 meeting?
- The board is presenting 3 director nominees at the Innovage Holding Corp 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Innovage Holding Corp 2025 meeting?
- Shareholders will vote on 2 proposals at the Innovage Holding Corp 2025 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.